Comparing the effect of Varenicline tablet with correction of attention bias in smoking cessation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181026041468N3

Enrollment

Registered

2021-08-09

Start date

2021-08-21

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine dependence. Nicotine dependence, cigarettes

Interventions

Intervention 1: Intervention group: In the intervention group, 12 sessions of correction of attention bias are performed with Prob dot task computer software 2 sessions per week. Each session lasts 30

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Smokers at the age of 18-60 Having a minimum literacy Informed consent

Exclusion criteria

Exclusion criteria: Request from the patient or the patient's legal guardian to leave the study at any time of the study Occurrence of harmful or intrusive side effects due to Varenicline or attention bias Severe smoker

Design outcomes

Primary

Measure	Time frame
Smoke cessation. Timepoint: Beginning ?middle and the end of the intervention. Method of measurement: Nicotine dependence scale (NDSS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Shayganfard

Arak University of Medical Sciences

mshayganfard@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026